We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Alison Halliday, PhD

Alison Halliday, PhD

Contact Us

Dr. Alison Halliday is an award-winning freelance science communications specialist with 20+ years of experience across academia, industry and the third sector – including ten years at the world’s largest cancer charity. She is skilled at translating complex information into jargon-free, engaging, stories – specializing in topics across the life sciences, medicine and health. After completing her PhD in molecular genetics at the University of Newcastle, she carried out five years of postdoctoral research at University College London before moving into science communications. She now works with a variety of clients to bring their research to life – including companies that need support with their product marketing, or organizations looking to engage with their audiences about the latest advances in biomedicine.


Latest Content
Recent Advances in Gene Therapy
Listicle

Recent Advances in Gene Therapy

Download this listicle to explore recent advances in gene therapy such as novel virus-free delivery systems, precision targeting using lipid nanoparticles and safer gene editing systems.
Heralding a New Era of RNA Therapeutics
Article

Heralding a New Era of RNA Therapeutics

Recent advances in mRNA technology, accelerated by the COVID-19 pandemic, mark the beginning of a therapeutic revolution in medicine.
Unpicking the Complexities of the Cancer Microbiome
Article

Unpicking the Complexities of the Cancer Microbiome

Understanding the relationship between cancer and the microbes that call our bodies home could transform the way the disease is managed in the future.
Leveraging the Power of Genomics To Detect and Track SARS-CoV-2 Variants
Article

Leveraging the Power of Genomics To Detect and Track SARS-CoV-2 Variants

Monitoring changes in the viral genome is continuing to play a crucial role in shaping the response to the COVID-19 pandemic.
High-Throughput Screening: Using a More Intelligent Approach for Hit Discovery
Article

High-Throughput Screening: Using a More Intelligent Approach for Hit Discovery

While industrial laboratories can screen vast numbers of potential drug compounds, many academic researchers are adopting more focused strategies.
The Role of the Host Immune Response in COVID-19: Friend or Foe?
Article

The Role of the Host Immune Response in COVID-19: Friend or Foe?

One of the biggest mysteries of the current pandemic is why outcomes from SARS-CoV-2 infection vary so widely between different people. Researchers are searching for clues in the host immune response to the virus.
Advances in Medicinal Chemistry
Article

Advances in Medicinal Chemistry

Medicinal chemists play a crucial role in drug discovery through the selection, synthesis and testing of a myriad of compounds. Recent advances in technologies are set to accelerate their progress.
The Importance of Diagnostics in Tackling the COVID-19 Pandemic
Article

The Importance of Diagnostics in Tackling the COVID-19 Pandemic

Large-scale testing and contact tracing are central to efforts to control the pandemic. This relies on diagnostic tests that can rapidly, accurately and reliably detect SARS-CoV-2.
Sequencing the Human Microbiome: Opening the Black Box
Article

Sequencing the Human Microbiome: Opening the Black Box

Researchers are using sequencing technologies to rapidly expand our knowledge of the human microbiome and identify undiscovered bacterial genomes.
The Therapeutic Antibody Revolution
Article

The Therapeutic Antibody Revolution

A crucial component of our immune system, antibodies are now the most rapidly growing class of approved biopharmaceutical drugs. We explore the past, present and future of therapeutic monoclonal antibodies.
Advertisement